The increased circulating and tissue proinflammatory cytokines in obesity may stimulate osteoclast activity and bone resorption through modifying the receptor activator of NF-κβ (RANK)/RANK ligand/osteoprotegerin pathway. Here, TNFRSF11A is linked to obesity disorder.